Valerie Morisset, EVP, R&D AND CSO at Eliem Therapeutics, Inc. (ELYM), sold 80,359 shares at $6.93 ($557K) on 2024-07-18, disclosed to the SEC on 2024-07-19.
Open-market sale of $557k ELYM by EVP, R&D AND CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.91 | 3,207 | $22K | 4.0% |
| 2 | $6.93 | 38,576 | $267K | 48.0% |
| 3 | $6.93 | 38,576 | $267K | 48.0% |
| Total | $6.93 avg | 80,359 | $557K | 100% |
| Filing → |
| ELYM | SELL | 2024-07-16 | $948K | — | Filing → |
| ELYM | SELL | 2024-07-11 | $737K | — | Filing → |
| ELYM | SELL | 2024-07-09 | $174K | — | Filing → |